Tarrabain Alex 4
4 · CEN BIOTECH INC · Filed Jun 3, 2021
Insider Transaction Report
Form 4
CEN BIOTECH INCCENBF
Tarrabain Alex
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2021-04-02+300,000→ 1,772,942 total - Other
Common Stock
2021-03-16+3,000→ 1,772,942 total - Other
Common Stock
2021-04-16+3,000→ 1,772,942 total - Other
Common Stock
2021-01-16+3,000→ 1,772,942 total - Other
Common Stock
2021-02-16+3,000→ 1,772,942 total - Conversion
Common Stock
2021-04-10$1.60/sh+30,000$48,000→ 1,772,942 total - Other
Common Stock
2021-05-16+3,000→ 1,772,942 total
Footnotes (3)
- [F1]300,000 shares of common stock of the issuer were granted by the issuer on April 2, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
- [F2]30,000 shares of common stock of the issuer were issued to the reporting person on April 10, 2021, pursuant to the conversion of a $48,000 convertible promissory note issued on October 26, 2016.
- [F3]3,000 shares of common stock of the issuer were issued to the reporting person on January 16, 2021, February 16, 2021, March 16, 2021, April 16, 2021 and May 16, 2021, as consideration for extending the maturity date of a promissory note dated January 14, 2018.